Health Catalyst CEO Simeon Kohl acquires $105,438 in company stock

Simeon Kohl, the CEO and a director at Health Catalyst, Inc. (NASDAQ:HCAT), purchased 59,000 shares of the company's common stock for a total value of $105,438 on September 14, 2026. At the time of the purchase, the stock was trading at $1.51 per share, which was lower than Kohl's purchase price of $1.7871 per share. InvestingPro analysis indicates that the company is still undervalued, with a fair value estimated at $2.21 per share.

Following the acquisition, Kohl now directly owns 2,856,385 shares of Health Catalyst common stock. The healthcare analytics company, valued at a market cap of $115 million, has experienced a 27% increase over the past six months despite a year-to-date decline of 37%. In addition to his stock purchase, Kohl was granted 2,747,385 restricted stock units (RSUs) under Health Catalyst's 2026 Employment Inducement Incentive Plan.

Each RSU entitles the recipient to one share of the company's common stock, subject to a vesting schedule. Specifically, 915,975 RSUs vest on September 4, 2027, with the remaining units vesting in eight equal quarterly installments.

The Form 4 filing, which reported these changes in beneficial ownership, was filed on September 16, 2026. Meanwhile, Health Catalyst reported its third-quarter 2026 financial results, surpassing Wall Street expectations. Adjusted earnings per share were $0.53, outperforming the anticipated loss of $0.05 per share, while revenue exceeded estimates at $56.2 million compared to the forecasted $55.44 million.

Despite positive financial performance, concerns about margins and churn remained among investors. No mergers or acquisitions involving Health Catalyst were reported during this period, and no recent upgrades or downgrades were issued by analyst firms.